6C47.70

ICD-11 MMS 2026-01

Synthetic cathinone-induced mood disorder

Description

Synthetic cathinone-induced mood disorder is characterised by mood symptoms (e.g., depressed or elevated mood, decreased engagement in pleasurable activities, increased or decreased energy levels) that develop during or soon after intoxication with or withdrawal from synthetic cathinones. The intensity or duration of the symptoms is substantially in excess of mood disturbances that are characteristic of Synthetic cathinone intoxication or Synthetic cathinone withdrawal. The amount and duration of synthetic cathinone use must be capable of producing mood symptoms. The symptoms are not better explained by a primary mental disorder (e.g., a Depressive disorder, a Bipolar disorder, Schizoaffective disorder), as might be the case if the mood symptoms preceded the onset of the synthetic cathinone use, if the symptoms persist for a substantial period of time after cessation of the synthetic cathinone use or withdrawal, or if there is other evidence of a pre-existing primary mental disorder with mood symptoms (e.g., a history of prior episodes not associated with synthetic cathinone use).

Index terms

  • Synthetic cathinone-induced mood disorder
  • Synthetic cathinone-induced mood disorder with depressive symptoms
  • Synthetic cathinone-induced mood disorder with manic symptoms
Show allHide
  • Synthetic cathinone-induced mood disorder with mixed depressive and manic symptoms

Exclusions from above levels

  • QE62 – Uncomplicated bereavement
  • QE84 – Acute stress reaction

Sibling codes

  • 6C47.71 – Synthetic cathinone-induced anxiety disorder
  • 6C47.72 – Synthetic cathinone-induced obsessive-compulsive or related syndrome
  • 6C47.73 – Synthetic cathinone-induced impulse control disorder

Foundation entity

Synthetic cathinone-induced mood disorder – http://id.who.int/icd/entity/507076012

Allowed postcoordination axes

Part of: 6C47.7: Certain specified synthetic cathinone-induced mental or behavioural disorders › 6C47: Disorders due to use of synthetic cathinones › 06: Mental, behavioural or neurodevelopmental disorders